首页> 外文期刊>Chemistry, an Asian journal >Designing New Analogs for Streamlining the Structure of Cytotoxic Lamellarin Natural Products
【24h】

Designing New Analogs for Streamlining the Structure of Cytotoxic Lamellarin Natural Products

机译:设计新的类似物以简化细胞毒性Lamellarin天然产物的结构

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Despite the therapeutic potential of marine-derived lamellarin natural products, their preclinical development has been hampered by their lipophilic nature, causing very poor aqueous solubility. In order to develop more drug-like analogs, their structure was streamlined in this study from both the cytotoxic activity and lipophilicity standpoints. First, a modified total synthetic route was successfully devised to construct a library of 59 systematically designed lamellarin analogs, which were then subjected to cytotoxicity and log P determinations. Along with the 25 first-generation lamellarins previously synthesized in our laboratory, the structure-activity and structure-lipophilicity relationships were extensively evaluated. Our results clearly indicated the additional structural requirements around the lamellarin skeleton which, when combined with those reported previously, can provide invaluable guidance for further modifications to increase the aqueous solubility of these compounds.
机译:尽管海洋来源的lamellarin天然产物具有治疗潜力,但其亲脂性质阻碍了它们的临床前开发,导致非常差的水溶性。为了开发更多类似药物的类似物,从细胞毒活性和亲脂性的角度出发,在本研究中简化了它们的结构。首先,成功设计了一条改良的总合成路线来构建59个系统设计的lamellarin类似物的文库,然后对其进行细胞毒性和log P测定。连同先前在我们实验室中合成的25种第一代薄片蛋白,对结构活性和结构亲脂性之间的关系进行了广泛的评估。我们的结果清楚地表明了薄片蛋白骨架周围的其他结构要求,当与先前报道的那些结合使用时,可以为进一步修饰以增加这些化合物的水溶性提供宝贵的指导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号